Southwest Neuroimmunologic Symposium -- April 26-28, 2007
at The Nativo Lodge in Albuquerque, New Mexico
Jointly sponsored by: The Cody Uner First Step Foundation &
Governor's Commission on Disability
click here for brochure and registration form
<http://hsc.unm.edu/cme/2007Web/Southwest%20Neuro/SouthwestNeuro2007Index.shtml>http://hsc.unm.edu/cme/2007Web/Southwest%20Neuro/SouthwestNeuro2007Index.shtml
The primary goal of this two day symposium is to bring together
patients with rare neuroimmnunoiogic disorders, professionals who
provide medical treatment and care to this population, and basic and
clinical scientists who specialize in research of these disorders.
The symposium will provide a unique approach and an exceptional
opportunity to foster communication and sharing of information
between the significant members of the neuroimmunologic community.
There are considerable benefits to be derived from the synergies of
bringing together these groups who possess a variety of perspectives
and experiences and who share very fundamental and common goals: a
better understanding of these rare disorders, improved quality of
life for this community of people, new treatments and ultimately a
cure for these neuroimmunologic disorders. This symposium represents
a major step in achieving all of these goals.
The symposium will provide a forum for discussion of many
neuroimmunologic disorders as they pertain to mechanisms of
autoimmunity in the nervous system. it will bring together patients,
caregivers, physicians, primary care doctors, family practitioners,
emergency medicine physicians, physicians, neurologists, nurses,
nurse practitioners and other allied health professionals. it will
focus on rare neuroimmunologic disorders, rather than on the most
common disease in this group, Multiple Sclerosis )MS). However,
participants will discuss advances in Ms specifically as these
advances inform and educate research in other neuroimmunologic disorders.
The goal is to provide up-to-date knowledge on the diagnosis and
management of diseases such as transverse myelitis TM), neuromyelitis
optica )NMO), and acute disseminated encephalopathy (ADEM). Most
importantly, this will be a platform for patients and caregivers to
interact with other patients and with physicians and learn about
novel therapies and clinical trials.
Who Should Attend
The clinical and science program is intended for scientists,
clinician-scientists, research fellows, graduate students and other
researchers interested in the shared and unique immunopathogenic
mechanisms in these rare disorders, and learning about emerging
immune, neuroprotective and restorative therapies as well as novel
imaging modalities.
it is also intended to update primary care practitioners,
neurologists, emergency medicine physicians, internists, family
practitioners, physician assistants, nurses, nurse practitioners,
gerontologists, rehabilitation physicians and other interested
individuals regarding the diagnosis and management of these rare
neuroimmunologic disorders. in addition, the goal of the course is to
educate patients and their caregivers on the management of these rare
disorders.
